Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement

PaperCitations, authors & open-access status

Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 9 citations, 2022 year and gold oa status.

9
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Eleonora Fusco
Author
SARS-CoV-2 and COVID-19 Research
Topic
SARS-CoV-2 and COVID-19 Research
Topic
COVID-19 Clinical Research Studies
Topic
CAR-T cell therapy research
Topic
470M+ articles · free account